American Century Companies
SNDX icon

American Century Companies’s Syndax Pharmaceuticals SNDX Stock Holding History

American Century Companies’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-9,803
Closed -$201K – 2951
2024
Q2 		$201K Buy
+9,803
New +$205K ﹤0.01% 2722
2023
Q2 		– Sell
-17,267
Closed -$365K – 2837
2023
Q1 		$365K Buy
17,267
+3,904
+29% +$97.1K ﹤0.01% 2228
2022
Q4 		$340K Sell
13,363
-3,332
-20% -$77.7K ﹤0.01% 2177
2022
Q3 		$401K Buy
+16,695
New +$375K ﹤0.01% 2032

Other funds holding SNDX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's SNDX Position: Q3 2024 in Review

American Century Companies sold out of Syndax Pharmaceuticals (SNDX) in Q3 2024, closing a stake of 9,803 shares — an estimated $201K sold.

American Century Companies first reported a position in SNDX in Q3 2022 and held it in 4 quarters. The position peaked at $401K in Q3 2022. 210 funds tracked by Wall St. Rank hold SNDX as of Q3 2024.

  • American Century Companies reported no remaining Syndax Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • American Century Companies sold 9,803 Syndax Pharmaceuticals shares in Q3 2024, an estimated $201K.
  • American Century Companies first reported a position in Syndax Pharmaceuticals in Q3 2022 and held it in 4 quarters.
  • American Century Companies's Syndax Pharmaceuticals position peaked at $401K in Q3 2022.
  • 210 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2024.

Based on American Century Companies's 13F filing for Q3 2024, filed 12 Nov 2024.